Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma

This study has been terminated.
(Adverse Events)
Sponsor:
Information provided by (Responsible Party):
Keith Flaherty, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01611675
First received: May 19, 2012
Last updated: April 4, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)